It was reported that glucagon-like peptide-1 (GLP-1)-based therapeutic methods may positively affect autophagy in PVAT, thus improving endothelial dysfunction caused by obesity (Costantino and Paneni, 2019). This evidence concerns the gene GCG and obesity disorder.